Correction
Accepted on 03 Nov 2025
Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia
in Substance Use Disorders and Behavioral Addictions
Correction
Accepted on 03 Nov 2025
in Substance Use Disorders and Behavioral Addictions
Review
Accepted on 03 Nov 2025
in Molecular Innate Immunity
Review
Accepted on 03 Nov 2025
in Pulmonary Medicine
Original Research
Accepted on 03 Nov 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Community Case Study
Accepted on 03 Nov 2025
in Public Health Education and Promotion
Original Research
Accepted on 03 Nov 2025
in Sustainable and Intelligent Phytoprotection
Systematic Review
Accepted on 03 Nov 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 03 Nov 2025
in Molecular Innate Immunity
Brief Research Report
Accepted on 03 Nov 2025
in Obstetrics and Gynecology
Review
Accepted on 03 Nov 2025
in Public Health Education and Promotion
Opinion
Accepted on 03 Nov 2025
in Cancer Genetics
Original Research
Accepted on 03 Nov 2025
in Biomechanics
Original Research
Accepted on 03 Nov 2025
in Obstetrics and Gynecology
Original Research
Accepted on 03 Nov 2025
in Virtual Reality in Medicine
Original Research
Accepted on 03 Nov 2025
in Environmental Degradation of Materials
Original Research
Accepted on 03 Nov 2025
in Vaccine Safety and Regulation